Soleno Therapeutics Inc financial data

Symbol
SLNO on Nasdaq
Location
203 Redwood Shores Parkway, Suite 500, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Capnia, Inc. (to 5/11/2017)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.02K % +384%
Debt-to-equity 18.6 % -89%
Return On Equity -43.3 % +84.6%
Return On Assets -36.5 % +65.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.9M shares +289%
Common Stock, Shares, Outstanding 38.4M shares +320%
Entity Public Float 33.1M USD +324%
Common Stock, Value, Issued 38K USD +280%
Weighted Average Number of Shares Outstanding, Basic 38.6M shares +271%
Weighted Average Number of Shares Outstanding, Diluted 38.6M shares +271%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 41.7M USD +131%
General and Administrative Expense 26.8M USD +149%
Operating Income (Loss) -72.6M USD -151%
Nonoperating Income (Expense) 7.23M USD +1381%
Net Income (Loss) Attributable to Parent -65.4M USD -130%
Earnings Per Share, Basic -1.83 USD/shares +33.9%
Earnings Per Share, Diluted -1.83 USD/shares +33.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57M USD +194%
Marketable Securities, Current 209M USD
Assets, Current 268M USD +1205%
Property, Plant and Equipment, Net 19K USD 0%
Operating Lease, Right-of-Use Asset 268K USD -50.5%
Intangible Assets, Net (Excluding Goodwill) 7.78M USD -20%
Other Assets, Noncurrent 83K USD -49.7%
Assets 304M USD +883%
Accounts Payable, Current 3.72M USD +7.96%
Employee-related Liabilities, Current 2.15M USD +84.5%
Liabilities, Current 9.15M USD +4%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 23.4M USD +26.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -153K USD
Retained Earnings (Accumulated Deficit) -320M USD -25.7%
Stockholders' Equity Attributable to Parent 281M USD +2159%
Liabilities and Equity 304M USD +883%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5M USD -86.2%
Net Cash Provided by (Used in) Financing Activities 938K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 38.4M shares +320%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -127M USD -1785%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 57M USD +194%
Deferred Tax Assets, Valuation Allowance 66M USD +15.7%
Deferred Tax Assets, Gross 67.9M USD +13.2%
Operating Lease, Liability 296K USD
Payments to Acquire Property, Plant, and Equipment 11K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.9M USD -158%
Lessee, Operating Lease, Liability, to be Paid 309K USD
Property, Plant and Equipment, Gross 101K USD 0%
Operating Lease, Liability, Current 296K USD +39.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 175K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13K USD +27560%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 51.5M USD +5.01%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.94M USD +51.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 64K USD -46.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 66M USD +15.7%
Share-based Payment Arrangement, Expense 17.7M USD +462%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%